Transactions: Licensing, Investment, and Partnerships Photo by Antonella Vilardo on Unsplash Cinda Biopharmaceuticals enters ADC On June 29, Cinda announced the signing of a non-exclusive, target-specific licensing agreement with Synaffix B.V. Synaffix will provide...
The Shanghai Stock Exchange and Technology Innovation Board (STAR Market) recently celebrated its second anniversary. The past two years have been busy ones. As of June 2, 2021, a total of 517 companies had applied for registration with STAR Market, of which 314 were...
The presence of robotic surgery has brought a lot of change to the OR. Compared with traditional surgery methods, robotic surgery can have such advantages as being less invasive and having higher precision, less blood, less scarring, reduced infection rates, and a...
Jiangsu Industrial Technology Research Institute (JITRI) was established in 2013. It is an industrial park for scientific and technological experimentation in Nanjing, Jiangsu Province, propelling companies from initial research to technology transformation and...
On November 27, 2020, at a signing ceremony in Shaxi, MyBioGate, Jiangsu Industrial Technology Research Institute, Taicang Innovation Investment Development, and Taicang Biomedical Industrial Park officially signed a contract to form the joint venture company TomoWave...
On March 17 of this year, the Chinese National Medical Products Administration (NMPA) approved the registration application for the innovative product “Disposable Electronic Ureteral Endoscopic Catheter” produced by Beijing Beifang Tengda Technology...
According to research from MyBioGate, in April, the global pharmaceutical industry reached at least 23 transactions, mainly mergers and acquisitions and licensing. M&A transactions mainly occurred between non-Chinese pharmaceutical companies. Two M&As were...
New drug approval: Telitacicept On March 12, the State Food and Drug Administration in China issued an announcement, authorizing conditional approval for RemeGen’s therapeutic biological product for injection, Telitacicept. The drug is an innovative drug TACl-Fc...
EGFR-TKI Lung cancer contributes to the highest number of new and fatal cases of malignant tumors in the world with regards to cancer cases. About 85% of lung cancer cases are non-small cell lung cancer (NSCLC). Most patients with NSCLC often have mutations that lead...
As spring arrived in March, cross-border transactions in the life sciences industry entered an additional month of growth. According to statistics from “Member Capital”, there were 13 Chinese asset licensing in transactions and 4 licensing out transactions...
In February of this year, Chinese and foreign pharmaceutical companies completed at least 30 transactions, including seven mergers and acquisitions, sixteen licensing transactions, and eleven R&D collaborations. The majority of mergers and acquisitions occurred...
Author: HE Sheng Attention deficit hyperactivity disorder (ADHD) is one of the most common mental disorders affecting children. Guidelines within the American Psychiatric Association’s Diagnostic and Statistical Manual, Fifth edition (DSM-5) are used to diagnose ADHD....
Targeted protein degradation involves targeting a disease-causing protein for degradation. The process makes small molecules with two active ends: one that binds to the protein of interest and the other that binds to a protein called E3 ubiquitin ligase. This causes...
MyBioGate is committed to connecting global healthcare innovations with Chinese resources. To bring our business into the next stage, we are now recruiting business development and finance adviser partner worldwide. We expect part-time employees to help us develop...
Website: https://www.jinaninvest.com/ In 2010, high-tech industrial parks began to focus on the development of the biomedical industry. At that time, the Jinan Innovation Zone (JIZ), located in Shandong Province in eastern China, had 123 biomedical companies with...
BeiGene Co., Ltd 2019 Revenue: US$ 428.21 million Number of Employees: 4,200+ Founded: 2010 Overview BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to...
“Give us a few more years and Genetron Health will be a leading precision medicine company, based in China but serving the world. This is our goal, ” Genetron Health CEO Sizhen Wang said in an interview with MyBioGate. One day prior to the interview, the...
A conversation with Harbour BioMed, I-Meb Biopharma, JW Therapeutics and Legend Biotech Founded in 2016, IPO in 2020: the fast development of these four companies is snapshot of Chinese It is both co-incident and destiny that the four Chinese biotech companies...
Biotech and Biopharma are big markets these days, especially when the threat of a pandemic is being felt firsthand across the world, as well as now that growing and aging populations are abundant and there is a growing need to treat existing diseases, cancers, and...
Starting up a company is a big step, and you likely already have your company going strong, expanding as you see fit, and, being a biotech or pharma company, committing large amounts of resources to research and development or manufacturing. If you are considering...
Recent Comments